Dr. Jacob Magee Sands, MD
- Medicare services, 2024
- 419
- Medicare patients, 2024
- 159
- Part D claims, 2024
- 99
- Publications
- 44
- Clinical trials
- 10
- Practice address
- 450 Brookline Avenue, Boston, MA 02115
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Sands' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jacob Magee Sands is a hematologist and oncologist in Boston, Massachusetts
Dr. Sands practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.
Dr. Sands' NPI, 1356491237, was assigned on January 11, 2007. Dr. Sands graduated from University of Cincinnati College of Medicine in 2005. Dr. Sands holds Massachusetts license 252674.
- NPI
- 1356491237NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1951469543
- NPI enumeration date
- January 11, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jacob Magee Sands practices at Dana-Farber Cancer Institute in Boston, Massachusetts
Dr. Sands' primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.
- Dana-Farber Cancer Institute450 Brookline Avenue, Boston, MA 02115
Source: Dmand AI Affiliation Data
Dr. Jacob Magee Sands is affiliated with 5 sites of care and 2 medical groups
Dr. Sands' primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Sands is also affiliated with Brigham and Women's Hospital. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Sands to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jacob Magee Sands' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sands practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dana-Farber Cancer Institute | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jacob Magee Sands is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Sands' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Sands' licenses on file in 2 states: Massachusetts and California.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
- Internal medicine, California
Hematologists and oncologists near Dr. Sands
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jacob Magee Sands billed Medicare for 419 services in 2024
CMS data shows 419 Medicare services from Dr. Sands across 5 procedure codes in 2024, for 159 Medicare patients. Medicare paid $42,449 for them.
Dr. Sands' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3552024: 41918%
Where Dr. Sands' Medicare services took place, 2024
- In an office13532%
- In a facility28468%
Dr. Sands compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Sands
- Massachusetts median
- Medicare services
- 419vs 49515% below
- Medicare patients
- 159vs 20020% below
- Part D claims
- 31vs 15179% below
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Sands' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Sands?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sands and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jacob Magee Sands treated 159 Medicare patients in 2024, average age 73
CMS counts 159 Medicare patients who saw Dr. Sands in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have cancer, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Sands' median patient age at 71, with 57% women.
Dr. Sands' Medicare patients by age, 2024
Dr. Sands' Medicare patients by sex, 2024
- Women9358%
- Men6642%
Chronic conditions among Dr. Sands' Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol71%
- Arthritis44%
- COPD43%
- Anxiety41%
- Ischemic heart disease35%
- Chronic kidney disease28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Sands' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women57%
- Men42%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jacob Magee Sands wrote 99 Medicare Part D claims in 2024
In 2024, Dr. Sands wrote 99 Medicare Part D claims for 46 patients. 71% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $329 in total drug cost. In 2023, CMS named 40 claims across 2 drugs.
Dr. Sands' Part D claims by kind of drug, 2024
- Generic70 claims71%
- Brand-name29 claims29%
Dr. Sands' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 402024: 3123%
Drugs named by CMS: 2 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jacob Magee Sands scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sands for performance year 2024, reported as part of a group. Dr. Sands accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sands as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Sands' MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jacob Magee Sands has 44 publications on record
Dmand AI links 44 papers to Dr. Sands, published from 2014 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Combined Chemotherapy Protocols. Dr. Sands has published most often in Lung Cancer. Dr. Sands' most frequent co-authors are Geoffrey R. Oxnard, MD, Suresh Sakkarai Ramalingam, MD and Hossein Borghaei, MD.
Dr. Sands' papers by year, 2016 to 2025
Topics Dr. Sands writes about most
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Antineoplastic Combined Chemotherapy Protocols
- Small Cell Lung Carcinoma
- Early Detection of Cancer
- Adenocarcinoma of Lung
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
Dr. Sands' most frequent co-authors
- Geoffrey R. Oxnard, MD7 shared papers
- Suresh Sakkarai Ramalingam, MD4 shared papers
- Hossein Borghaei, MD3 shared papers
Recent publications by Dr. Sands
See who Dr. Sands researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sands works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jacob Magee Sands has worked on 10 clinical trials
Dmand AI links Dr. Sands to 10 clinical trials, 3 of them phase 1/2 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Small Cell Lung Carcinoma. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Sands that name 2 trials.
Clinical trials with Dr. Sands by phase
- NonePhase 1: no trials
- 3Phase 1/2: 3 trials
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Sands' trials
- Carcinoma, Bronchogenic
- Carcinoma, Non-Small-Cell Lung
- Small Cell Lung Carcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Carcinoma, Medullary
Investigators on the most trials with Dr. Sands
- Marc A. Rovito, MD3 shared trials
- Preston D. Steen, MD3 shared trials
- Sheetal Sumat Acharya, MD2 shared trials
Recent clinical trials with Dr. Sands
A Phase II Study of Olaparib Plus Cediranib in Combination With Standard Therapy for Small Cell Lung Cancer (opens in a new tab)
A Multi-Center, Phase Ib/II Study of Combination Treatment of APG-1252 With Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer (opens in a new tab)
A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) (opens in a new tab)
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jacob Magee Sands received $407,134 in industry payments from 2016 to 2025
CMS Open Payments shows 358 general payments to Dr. Sands from 31 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. AstraZeneca Pharmaceuticals LP paid the most, $134,031. It also lists 7 research payments totaling $11,951 from 2018 to 2025, naming 2 clinical trials.
General payments to Dr. Sands by program year, 2016 to 2025
General payments to Dr. Sands by kind, 2016 to 2025
- Consulting fees$303,50475%
- Speaker and faculty fees$46,83812%
- Travel and lodging$28,3727%
- Food and beverage$15,3154%
- Other$13,1073%
Companies that paid Dr. Sands the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jacob Magee Sands graduated from University of Cincinnati College of Medicine
Dr. Sands graduated from University of Cincinnati College of Medicine in 2005.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Jacob Magee Sands's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jacob Magee Sands
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jacob Magee Sands' NPI number?
Dr. Jacob Magee Sands' NPI number is 1356491237. It was assigned on January 11, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Jacob Magee Sands?
Dr. Jacob Magee Sands is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Jacob Magee Sands practice?
Dr. Sands practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Sands' primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Dr. Sands to 1 hospital, 1 group practice or clinic, 1 home health agency and 1 medical group.
What is Dr. Jacob Magee Sands' medical license number?
Dr. Sands holds Massachusetts license 252674, one of the licenses on file in 2 states.
Which states has Dr. Jacob Magee Sands been licensed in?
Dmand AI has state licenses on file for Dr. Sands in Massachusetts and California.
Which hospitals is Dr. Jacob Magee Sands affiliated with?
Dr. Sands practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Sands is also affiliated with Brigham and Women's Hospital. Dmand AI links Dr. Sands to 1 more hospital.
What medical group is Dr. Jacob Magee Sands part of?
Dr. Sands is linked to Lahey Clinic. Dmand AI links Dr. Sands to 1 more medical group.
Does Dr. Jacob Magee Sands accept Medicare?
Yes. CMS data shows Dr. Sands billed Medicare for 419 services in 2024, and Dr. Sands accepts Medicare assignment.
Does Dr. Jacob Magee Sands offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Sands as offering telehealth services.
What is Dr. Jacob Magee Sands' MIPS score?
Dr. Sands' MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Jacob Magee Sands see?
CMS counts 159 Medicare patients who saw Dr. Sands in 2024, with an average age of 73.
What services does Dr. Jacob Magee Sands bill to Medicare?
In 2024, Dr. Sands' most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and hospital inpatient care (99232).
Where did Dr. Jacob Magee Sands go to medical school?
Dr. Sands graduated from University of Cincinnati College of Medicine in 2005.
What drugs does Dr. Jacob Magee Sands prescribe most?
In 2024 Medicare Part D data, Dr. Sands' most prescribed drugs by claims were Dexamethasone and Prochlorperazine Maleate.
Has Dr. Jacob Magee Sands received payments from drug or device companies?
CMS Open Payments shows $407,134 in general payments to Dr. Sands from 31 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Jacob Magee Sands been practicing?
Dr. Sands graduated from medical school in 2005, 21 years ago.
Does Dr. Jacob Magee Sands do research?
Dmand AI links 44 publications to Dr. Sands, published from 2014 to 2025. Dr. Sands has worked on 10 clinical trials.
Who does Dr. Jacob Magee Sands publish with?
Dr. Sands' most frequent co-authors are Geoffrey R. Oxnard, MD (7 shared papers), Suresh Sakkarai Ramalingam, MD (4 shared papers) and Hossein Borghaei, MD (3 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card